SynthesisFrontiers in endocrinology2025
Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Lianzhi Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.